Company news

Organogenesis Holdings Inc. news in 2024

Organogenesis Holdings Inc.'s news releases, calls and decks from 2024, newest first.

View company

Organogenesis Expands Manufacturing Capacity to Support Future Growth

November 21, 2024

Organogenesis Commends Final LCDs

November 14, 2024

Organogenesis Holdings Inc. Reports Third Quarter 2024 Financial Results

November 11, 2024

Organogenesis Holdings Inc. Announces $130 Million Private Placement Offering of Series A Convertible Preferred Stock

November 11, 2024

Organogenesis Reports Positive Interim Analysis of Second Phase 3 Clinical Trial of ReNu for Knee Osteoarthritis

November 10, 2024

Organogenesis Holdings Inc. to Report Third Quarter of Fiscal Year 2024 Financial Results on November 12, 2024

October 15, 2024

Organogenesis Announces Publication of Randomized Clinical Trial Results Demonstrating the Safety and Efficacy of NuShield for Diabetic Foot Ulcers

September 30, 2024

Organogenesis Shares ReNu® Program Update

August 7, 2024

Organogenesis Holdings Inc. Reports Second Quarter 2024 Financial Results

August 7, 2024

Organogenesis Holdings Inc. to Report Second Quarter of Fiscal Year 2024 Financial Results on August 8, 2024

July 14, 2024

Organogenesis Holdings Inc. to Participate in the Truist Securities MedTech Conference

June 5, 2024

Organogenesis Holdings Inc. Reports First Quarter 2024 Financial Results

May 8, 2024

Organogenesis Achieves Primary Endpoint in Phase 3 Clinical Trial of ReNu® for Knee Osteoarthritis

May 1, 2024

Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2024 Financial Results on May 9, 2024

April 15, 2024

Organogenesis Announces Favorable Court Ruling Dismissing Securities Fraud Case

April 2, 2024

Organogenesis Holdings Inc. Reports Fourth Quarter 2023 and Fiscal Year 2023 Financial Results; Introduces Fiscal Year 2024 Guidance

February 28, 2024

Organogenesis Holdings Inc. to Participate in the BTIG Snowbird MedTech, Digital Health, Life Science and Diagnostic Tools Conference

February 11, 2024

Organogenesis Holdings Inc. to Report Fourth Quarter and Fiscal Year 2023 Financial Results on February 29, 2024

February 7, 2024

Calls in 2024